P01.06 Overcoming resistance to ICI therapy by downregulating the expression of neuropilin-1 with antisense oligonucleotides

Bibliographic Details
Main Authors: A Zippelius, L Rodríguez, J Festag, S Michel, R Klar, F Jaschinski, A Maaske, N Kirchhammer, M Buchi
Format: Article
Language:English
Published: BMJ Publishing Group 2024-03-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1827312631969480704
author A Zippelius
L Rodríguez
J Festag
S Michel
R Klar
F Jaschinski
A Maaske
N Kirchhammer
M Buchi
author_facet A Zippelius
L Rodríguez
J Festag
S Michel
R Klar
F Jaschinski
A Maaske
N Kirchhammer
M Buchi
author_sort A Zippelius
collection DOAJ
first_indexed 2024-04-24T21:46:32Z
format Article
id doaj.art-1be7773ed1014cb4954eba0091f632e2
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-04-24T21:46:32Z
publishDate 2024-03-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-1be7773ed1014cb4954eba0091f632e22024-03-20T20:50:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262024-03-0112Suppl 110.1136/jitc-2024-ITOC10.16P01.06 Overcoming resistance to ICI therapy by downregulating the expression of neuropilin-1 with antisense oligonucleotidesA Zippelius0L Rodríguez1J Festag2S Michel3R Klar4F Jaschinski5A Maaske6N Kirchhammer7M Buchi82Cancer Immunology, Department of Biomedicine, University Hospital Basel, Basel, SwitzerlandRheumatology Department, Hospital Clínico San Carlos, Madrid, Spain1Secarna Pharmaceuticals GmbH and Co. KG, Planegg, GermanySecarna Pharmaceuticals GmH and Co. KG, Planegg/Martinsried, GermanySecarna Pharmaceuticals GmH and Co. KG, Planegg/Martinsried, GermanySecarna Pharmaceuticals GmH and Co. KG, Planegg/Martinsried, Germany1Secarna Pharmaceuticals GmbH and Co. KG, Planegg, Germany2Cancer Immunology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland2Cancer Immunology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland
spellingShingle A Zippelius
L Rodríguez
J Festag
S Michel
R Klar
F Jaschinski
A Maaske
N Kirchhammer
M Buchi
P01.06 Overcoming resistance to ICI therapy by downregulating the expression of neuropilin-1 with antisense oligonucleotides
Journal for ImmunoTherapy of Cancer
title P01.06 Overcoming resistance to ICI therapy by downregulating the expression of neuropilin-1 with antisense oligonucleotides
title_full P01.06 Overcoming resistance to ICI therapy by downregulating the expression of neuropilin-1 with antisense oligonucleotides
title_fullStr P01.06 Overcoming resistance to ICI therapy by downregulating the expression of neuropilin-1 with antisense oligonucleotides
title_full_unstemmed P01.06 Overcoming resistance to ICI therapy by downregulating the expression of neuropilin-1 with antisense oligonucleotides
title_short P01.06 Overcoming resistance to ICI therapy by downregulating the expression of neuropilin-1 with antisense oligonucleotides
title_sort p01 06 overcoming resistance to ici therapy by downregulating the expression of neuropilin 1 with antisense oligonucleotides
work_keys_str_mv AT azippelius p0106overcomingresistancetoicitherapybydownregulatingtheexpressionofneuropilin1withantisenseoligonucleotides
AT lrodriguez p0106overcomingresistancetoicitherapybydownregulatingtheexpressionofneuropilin1withantisenseoligonucleotides
AT jfestag p0106overcomingresistancetoicitherapybydownregulatingtheexpressionofneuropilin1withantisenseoligonucleotides
AT smichel p0106overcomingresistancetoicitherapybydownregulatingtheexpressionofneuropilin1withantisenseoligonucleotides
AT rklar p0106overcomingresistancetoicitherapybydownregulatingtheexpressionofneuropilin1withantisenseoligonucleotides
AT fjaschinski p0106overcomingresistancetoicitherapybydownregulatingtheexpressionofneuropilin1withantisenseoligonucleotides
AT amaaske p0106overcomingresistancetoicitherapybydownregulatingtheexpressionofneuropilin1withantisenseoligonucleotides
AT nkirchhammer p0106overcomingresistancetoicitherapybydownregulatingtheexpressionofneuropilin1withantisenseoligonucleotides
AT mbuchi p0106overcomingresistancetoicitherapybydownregulatingtheexpressionofneuropilin1withantisenseoligonucleotides